Drug Type Degradable Molecular Glue |
Synonyms SJ-42872 |
Target |
Action inhibitors |
Mechanism PPIL4 inhibitors(peptidylprolyl isomerase like 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Leukemia | Preclinical | United States | 17 Apr 2026 | |
| Medulloblastoma | Preclinical | United States | 17 Apr 2026 |





